Novo Nordisk adds Anthropic's Claude to drug-research workflow
Novo Nordisk (NYSE: NVO) will test Anthropic’s Claude Science on selected scientific questions and deploy it in its drug-research workflow,
S. 125. Novo said it will start by testing Claude Science on selected scientific questions while also deploying…